Physician profile
Robert Rosenberg
NPI 1598764482
$3,673.10
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,741 · 2020: $174 · 2022: $490 · 2023: $195 · 2024: $73.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,994.46 | 2019-2022 | |
| Horizon Therapeutics Plc | $424.16 | 2019-2023 | |
| Amgen INC. | $346.68 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $197.20 | 2022-2024 | Saphnelo |
| Abbvie INC. | $158.50 | 2019-2020 | |
| Glaxosmithkline, LLC. | $136.66 | 2019-2022 | |
| Pacira Therapeutics, INC. | $72.65 | 2019 | |
| Lilly USA, LLC | $68.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $64.52 | 2019-2020 | |
| Radius Health, INC. | $57.98 | 2019 | |
| Pfizer INC. | $55.43 | 2019 | |
| Ucb, INC. | $47.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $29.14 | 2019 | |
| Merck Sharp & Dohme LLC | $19.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.